Seeing Is Believing

Currently out of the existing stock ratings of Tiago Fauth, 163 are a BUY (76.17%), 44 are a HOLD (20.56%), 7 are a SELL (3.27%).
Analyst Tiago Fauth, currently employed at WELLS FARGO, carries an average stock price target met ratio of 45.77% that have a potential upside of 23.52% achieved within 126 days.
Tiago Fauth’s has documented 426 price targets and ratings displayed on 43 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on TECX, Tectonic Therapeutic at 07-Aug-2026.
Analyst best performing recommendations are on HGEN (HUMANIGEN).
The best stock recommendation documented was for HGEN (HUMANIGEN) at 7/13/2022. The price target of $0.5 was fulfilled within 2 days with a profit of $0.11 (18.03%) receiving and performance score of 90.16.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 05-Jan-2021
$9
$-2.32 (-20.49%)
$7
Buy Since 07-Jul-2025
$4
$-3.38 (-45.80%)
$5
Buy Since 05-Dec-2023
$10
$2.62 (35.50%)
$5
Buy Since 16-May-2025
$10
$2.62 (35.50%)
Which stock is Tiago Fauth is most bullish on?
What Year was the first public recommendation made by Tiago Fauth?